NO20073699L - Stabile protaglandin-inneholdende preparater - Google Patents

Stabile protaglandin-inneholdende preparater

Info

Publication number
NO20073699L
NO20073699L NO20073699A NO20073699A NO20073699L NO 20073699 L NO20073699 L NO 20073699L NO 20073699 A NO20073699 A NO 20073699A NO 20073699 A NO20073699 A NO 20073699A NO 20073699 L NO20073699 L NO 20073699L
Authority
NO
Norway
Prior art keywords
protaglandin
stable
prostaglandin
containing preparations
acid ester
Prior art date
Application number
NO20073699A
Other languages
English (en)
Norwegian (no)
Inventor
Ian Gardner Cameron Mcaffer
Peter Tasko
Victor Deaciuc
Michael Hagan
Hashem Heiati
Karen Kostick Jette
Gregory C Visor
Original Assignee
Breath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breath Ltd filed Critical Breath Ltd
Publication of NO20073699L publication Critical patent/NO20073699L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20073699A 2005-01-20 2007-07-17 Stabile protaglandin-inneholdende preparater NO20073699L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501192.9A GB0501192D0 (en) 2005-01-20 2005-01-20 Stable prostaglandin-containing compositions
PCT/US2006/001626 WO2006078659A2 (fr) 2005-01-20 2006-01-18 Compositions stables contenant de la prostaglandine

Publications (1)

Publication Number Publication Date
NO20073699L true NO20073699L (no) 2007-10-19

Family

ID=34259405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073699A NO20073699L (no) 2005-01-20 2007-07-17 Stabile protaglandin-inneholdende preparater

Country Status (16)

Country Link
US (2) US8084501B2 (fr)
EP (1) EP1843744A2 (fr)
JP (2) JP2008528490A (fr)
KR (1) KR20070094793A (fr)
CN (1) CN101106973A (fr)
AU (1) AU2006206649B2 (fr)
BR (1) BRPI0606606A2 (fr)
CA (1) CA2595237A1 (fr)
CZ (1) CZ2007555A3 (fr)
GB (1) GB0501192D0 (fr)
IL (1) IL184111A0 (fr)
IS (1) IS8665A (fr)
NO (1) NO20073699L (fr)
NZ (1) NZ556117A (fr)
WO (1) WO2006078659A2 (fr)
ZA (1) ZA200705428B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
EP2094839B1 (fr) 2006-12-08 2020-02-05 University of Rochester Expansion de cellules souches hématopoïétiques
DK2116241T3 (en) 2007-01-26 2016-06-06 Pola Pharma Inc pharmaceutical composition
JPWO2008096804A1 (ja) * 2007-02-07 2010-05-27 テイカ製薬株式会社 ラタノプロスト含有点眼剤
JP2008247828A (ja) * 2007-03-30 2008-10-16 Wakamoto Pharmaceut Co Ltd ラタノプロストを含有する水性医薬組成物。
DK2227213T3 (da) * 2007-11-30 2013-01-02 Toltec Pharmaceuticals Llc Sammensætninger og fremgangsmåder til behandling af vaginale infektioner og patogene, vaginle biofilm
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (fr) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Procédé et composition pour traiter l'hypertension oculaire et le glaucome
WO2010016044A1 (fr) * 2008-08-05 2010-02-11 University College Cork, National University Of Ireland, Cork Traitement de la dégénérescence de la rétine
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
WO2011027778A1 (fr) * 2009-09-01 2011-03-10 株式会社アールテック・ウエノ Composition pour une administration topique aux yeux destinée à une utilisation dans le traitement de l'hypertension oculaire et du glaucome
US20130011354A1 (en) * 2009-11-09 2013-01-10 Allergan, Inc. Compositions For Enhancing Hair Growth
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
CN103596572A (zh) * 2011-04-12 2014-02-19 株式会社·R-技术上野 水性眼用组合物
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
CN104208015A (zh) * 2013-05-29 2014-12-17 天津金耀集团有限公司 含有曲伏前列腺素和防腐剂的眼部制剂
ES2747302T3 (es) * 2015-06-09 2020-03-10 Medproject Pharma Entw Und Vertriebsgesellschaft Mbh Gel oftálmico de bimatoprost aplicable en gotas
JP6931493B2 (ja) * 2017-06-22 2021-09-08 ヨンスン ファイン ケミカル カンパニー，リミテッド 緑内障治療用点眼組成物
JP2024516834A (ja) * 2021-04-30 2024-04-17 イノベント バイオロジクス（スーチョウ）カンパニー，リミティド Ｏｘｍ３保存剤、ｏｘｍ３製剤および調製方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1366215A (en) * 1916-08-05 1921-01-18 Vaporackumulator Ab Supplementary power plant for electric centrals
US5165918A (en) * 1988-06-28 1992-11-24 Ciba-Geigy Corporation Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same
DE69105349T2 (de) * 1990-05-22 1995-04-06 Ueno Seiyaku Oyo Kenkyujo Kk Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
CA2086874E (fr) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methodes d'administration du taxol
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
SE9702681D0 (sv) 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
SE9702706D0 (sv) 1997-07-11 1997-07-11 Pharmacia & Upjohn Ab Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
WO1999012899A1 (fr) 1997-09-09 1999-03-18 The Procter & Gamble Company Procede de production d'analogues de prostaglandine f
US6646001B2 (en) * 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
AU6132999A (en) 1998-10-05 2000-04-26 Alcon Laboratories, Inc. Stannane synthesis of prostanoids
US6417228B1 (en) * 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
SE9900025D0 (sv) 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
US20040097592A1 (en) 2000-09-13 2004-05-20 Kenji Morishima Eye drops
US20030018079A1 (en) * 2000-11-13 2003-01-23 Richardson Helene Treatment
US6743439B1 (en) * 2001-06-27 2004-06-01 Alcon, Inc. Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
US7351404B2 (en) * 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
NO317079B1 (no) * 2002-08-02 2004-08-02 Maritime Hydraulics As Stigerorstrekkanordning
US6864282B2 (en) * 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
CA2498233C (fr) 2002-09-09 2012-08-14 Santen Pharmaceutical Co., Ltd. Solution ophtalmique transparente contenant du latanoprost comme principe actif
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma

Also Published As

Publication number Publication date
AU2006206649A1 (en) 2006-07-27
US8084501B2 (en) 2011-12-27
CZ2007555A3 (cs) 2007-10-10
GB0501192D0 (en) 2005-03-02
AU2006206649B2 (en) 2010-05-27
NZ556117A (en) 2009-10-30
IS8665A (is) 2007-08-02
WO2006078659A2 (fr) 2006-07-27
WO2006078659A8 (fr) 2007-08-30
KR20070094793A (ko) 2007-09-21
CA2595237A1 (fr) 2006-07-27
EP1843744A2 (fr) 2007-10-17
ZA200705428B (en) 2008-09-25
BRPI0606606A2 (pt) 2009-07-07
JP2008528490A (ja) 2008-07-31
US20120065258A1 (en) 2012-03-15
US20060270735A1 (en) 2006-11-30
IL184111A0 (en) 2007-10-31
CN101106973A (zh) 2008-01-16
WO2006078659A3 (fr) 2006-11-16
JP2013056948A (ja) 2013-03-28

Similar Documents

Publication Publication Date Title
NO20073699L (no) Stabile protaglandin-inneholdende preparater
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
EA200870019A1 (ru) Лактамовые соединения и способы их применения
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
NO20071742L (no) Kinazoliner som er nyttige som modulatorer av ionekanaler
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20080141L (no) Indanderivater som modulatorer av ionekanaler
BRPI0511111A (pt) compostos de pirrol como inibidores de cinase de proteìna de erk, sua sìntese e seus intermediários
EA200801492A1 (ru) Фармацевтическое применение замещенных амидов
MX2022009942A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
WO2007103719A3 (fr) MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
NO20076447L (no) Bicykliske derivater som modulatorer av ionekanaler
NO20083220L (no) Heterocykliske derivater som modulatorer for ionekanaler
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
MY144659A (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
NO20081975L (no) Diarylamin-inneholdende forbindelser og sammensetninger, og deres anvendelse som modulatorer av C-kit-reseptorer
UA115131C2 (uk) Сполуки боронатного ефіру і його фармацевтичні рецептури
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
EA200800783A1 (ru) Композиция тразодона для введения один раз в день

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application